Literature DB >> 2376169

Flow characteristics of bioprosthetic heart valves.

M Y Rashtian1, D M Stevenson, D T Allen, A P Yoganathan, E C Harrison, W A Edmiston, S H Rahimtoola.   

Abstract

A review of the in vivo and in vitro fluid dynamic performance of three bioprosthetic heart valves is presented. Data on Hancock porcine valves (standard models 242 aortic and 342 mitral and modified orifice model 250 aortic), Carpentier-Edwards porcine valves (model 2625 aortic and 6625 mitral), and the Ionescu-Shiley pericardial valve are reviewed. These valves were chosen because of their past or present popularity in clinical use and because of the variation in fluid dynamic performance reported by different investigators. The flow parameters that are reported include in vivo and in vitro mean pressure drop, cardiac output or cardiac index, regurgitant volume, effective orifice area, and performance index. These data provide a framework for differentiation of normal and abnormal bioprosthetic valve function.

Mesh:

Year:  1990        PMID: 2376169     DOI: 10.1378/chest.98.2.365

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Factors affecting survival after mitral valve replacement in patients with prosthesis-patient mismatch.

Authors:  Abdulhameed Aziz; Jennifer S Lawton; Hersh S Maniar; Michael K Pasque; Ralph J Damiano; Marc R Moon
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

2.  Doppler sonographic evaluation of mechanical and bioprosthetic mitral valve prostheses during exercise with a rate corrected pressure half time.

Authors:  P Weiss; A Hoffmann; D Burckhardt
Journal:  Br Heart J       Date:  1992-06

3.  Fluid-Structure Interaction Models of Bioprosthetic Heart Valve Dynamics in an Experimental Pulse Duplicator.

Authors:  Jae H Lee; Alex D Rygg; Ebrahim M Kolahdouz; Simone Rossi; Stephen M Retta; Nandini Duraiswamy; Lawrence N Scotten; Brent A Craven; Boyce E Griffith
Journal:  Ann Biomed Eng       Date:  2020-02-07       Impact factor: 3.934

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.